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Infection of susceptible adult mice with Friend virus complex (FV), 1 consist- 
ing of spleen focus-forming virus (SFFV) and lymphatic leukemia virus (LLV), 
results in a  rapidly progressing erythroleukemia (1) and a  profound immuno- 
suppression (2). Several genes are involved in the regulation of host responses 
to  FV.  Genes  linked  to  H-2,  the  major  histocompatibility  complex  of the 
species, appear to be involved in interactions between immunocompetent cells 
with  virus-infected  cells  (3)  and  are  involved  in  recovery from  the  active 
infection with  FV  (4). Physical association  between  FV  and H-2  molecules 
have been detected (5). The Friend virus-1  (Fv-1) gene controls resistance to 
LLV  (6),  the  helper  virus  for  SFFV.  Resistance  to  SFFV,  which  induces 
erythroleukemia seen grossly as splenic foci, is controlled by the Friend virus-2 
(Fv-2) gene. Susceptibility to spleen focus formation is dominant over resistance 
(6).  Mice of a  narrow  ancestral  group of strains  (7),  which include  C57BL, 
C57L,  and C58, are resistant to the erythropoietic effects of SFFV, i.e., are Fv- 
2 rr,  and are also relatively resistant to the immunosuppressive effects of FV 
(8). 
Marrow-dependent (M)  cells appear to  mediate the genetically determined 
resistance of C57BL/6 mice to both the erythropoietic and immunosuppressive 
effects of FV (9, 10). M cells are the effector cells responsible for the rejection of 
allogeneic or  incompatible  parental-strain  hemopeietic cell  grains  (11). The 
cells are so named because continuous irradiation of the marrow microenviron- 
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ment with beta particles  emitted by the bone-seeking isotope,  ~Sr, abrogates 
the ability  of  irradiated  mice to reject  marrow cell  allograf~s  without altering 
thymus-dependent  (T) or bursa equivalent-dependent  (B) cell  functions (12). 
C57BL/6 mice treated  with ~Sr and later  infected  with FV develop erythroleu- 
kemia and are immunosuppressed  (9).  The genetic  resistance  or susceptibility 
to FV induced immunosuppression in  vivo appears to  be reflected  in an in  vitro 
model involving stimulation of  lymphocytes with mitogens in the presence or 
absence of FV (10).  For example, spleen cells  from C57BL/6 mice which are 
resistant  to FV in vitro  are rendered susceptible  by prior  treatment of  donors 
with S~Sr  to eliminate M  cells.  Further analysis of the model indicated that 
inhibition  of  lymphocyte mitogenesis produced by FV in  vitro  is  mediated via  T 
suppressor cells. M  cells regulate the number  and/or function of such T- 
suppressor cells  in the body (13).  In this  paper, we have performed genetic 
experiments to determine if  the same or different  genes control  resistance  to 
immunosuppression  by FV  in vitro and spleen focus formation  or marrow 
allograft reactivity in vivo. We have identified a  gene, Fv-3, which segregates 
independently  from Fv-2  but  which  is  also  dominant  for  susceptibility.  The 
ability to reject marrow cell allografts in one donor-host combination was also 
not controlled by this gene.  In a forthcoming paper,  a genetic  analysis will be 
presented which indicates that Fv-3 controls resistance to FV induced immuno- 
suppression in vitro  and in vivo.  2 
Materials and Methods 
Mice.  Inbred DBA/2, BI0.D2, and C57BL/6  (B6) mice were purchased from The Jackson 
Laboratory, Bar Harbor, Maine. 129/Rr (129)  mice were bred in our animal facility.  Mice of  the 
parental strain  were mated to  produce DBA/2 × B10.D2 and 129 x B6 FI hybrid mice (with both 
strains  in crosses  as males or females). F2 progeny were produced by intercrossing  the Fx mice. 
(DBA/2 × B10.D2)Fs mice were backcrossed to  DBA/2 or to B10.D2 mice (with males and females 
of  each members of  the matings). Mice of  both sexes were tested  when 8-  to 12-wks of  age. Sex of 
the individual mice or  of  the parents producing the offspring  did not affect  the results  obtained. 
Virus.  The Mirand strain  of  NB-tropic FV (14)  was used. The virus is maintained by serial 
in vivo passages in BALB/c mice and virus  stocks  are  prepared as  20% wt/vol cell-free  extracts  of 
leukemic spleens.  The spleen focus assay is  used to titrate  the virus and the titer  is  expressed in 
focus-forming unite (FFU), where 1 FFU results  in the appearance of i spleen focus  8-10 days 
after  intravenous injection  of  the virus into  susceptible  hosts (15).  To type for  Fv-2, mice were 
infected  with 50 FFU of  FV intravenously. The spleens were removed 9 days later  and fixed  in 
Bouin's fluid.  The mice whose spleens were devoid of  any loci  were designated Fv-2", whereas 
the mice whose spleens contained foci  were either  Fv-2  ~s  or  Fv-2  ~ and were termed "susceptible". 
Progeny testing of mice to distinguish between Fv-2  ~  and Fv-2  ~8 mice among "susceptible" 
population was not performed. 
Assay for  Immunosuppression by  FV.  The procedure for  preparing lymphoid cell  suspensions, 
culturing cells  with mitogens,  and infecting  the cultures with graded doses of FV have been 
described in detail (10).  Spleen and thymus cells  were harvested and cultured in RPMI  1640 
medium  (Grand Island Biological Co., Grand Island, N.Y.) containing  10% fetal  calf  serum. 
Spleen cells  were washed once and were cultured in wells of  Microtest II  plates (Falcon Plastics, 
Division of BioQuest, Oxnard, Calif.).  Each well contained  0.2-ml vol with 10  ~ spleen cells. 
Triplicate samples contained  (a) 0.5 fig Concanavalin A  (Con A) (Calbiochem,  San Diego, 
2  V.  Kumar,  P. Resnick,  J. W.  Eastcott, and M.  Bennett.  1977. Mechanism  of genetic 
resistance  to Friend virus leukemia in mice. V. Relevance of  Fv-3 gene in the regulation of  in 
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Calif.),  (b)  FV,  100-500  FFU  (c)  Con  A  and  FV,  or  (d)  neither  Con  A  nor  FV.  In  each 
experiment, three doses of FV were tested. 
Thymus cells were washed three times and cultured in 12  x  75 mm plastic test tubes (Falcon 
Plastics). Preliminary experiments indicated that thymus cells responded to Con A much better 
in tube cultures than in Microtest II plates.  Each tube contained 3-ml vol and 6  x  106 thymus 
cells. Triplicate samples contained (a) Con A, 2/~g/ml,  (b) FV, 300 FFU/ml,  (c) Con A plus FV, 
or (d) neither Con A nor FV. 
[SH]thymidine (New England Nuclear, Boston, Mass.) was added to each well of Micretest II 
plates (0.5 ~tCi) or to each test tube (1/~Ci) 48 h  after initiation of the culture. The cultures were 
harvested 18 h later  for liquid  scintillation  counting. A MASH  II automatic harvester was used 
to collect  trichloroacetic  acid (TCA) precipitable  material when Microtest II plates were used. 
The test  tube cultures  were harvested by washing the tubes three times with 5 ml of  phosphate- 
buffered saline  and three times with 5 ml of  5% cold  TCA. After the final  wash, a mixture of  0.5 
ml methanol and 1.5 ml alkali (protosol,  New England Nuclear) was added to each pellet.  The 
tubes were incubated in a water bath at 56°C for 1 h to dissolve  the pellet.  The content of  each 
tube was then processed for  liquid  scintillation  counting. 
The results  are  expressed as  A blastegenesis,  which represents mean [SH]thymidine incorpora- 
tion (counts per minute, cpm), in appropriate cultures with Con A minus cultures without Con 
A, or  groups (a)-(d)  and (c)-(b)  described above. FV alone did not significantly  affect  incorpora- 
tion  values of  [SH]thymidine. Therefore, FV-induced changes in  A blastogenesis  reflected  changes 
in response to Con A  and not to proliferation  of unstimulated cultures. The percentage (%) 
suppression of  A blastogenesis by FV was calculated by the formula, %  suppression = mean A 
blastogenesis  Control-FV/Control  x 100,  where control  is  the uninfected culture. 
Assay for Marrow Allografl Rejection.  The procedure has been described in detail elsewhere 
(16).  The recipients in  these experiments  were F2  progeny  of reciprocal  (DBA/2  x  B10.D2)F~ 
intercross matings. These mice are H-2 d. The donors of the marrow cells were C57BL/6 mice (H- 
2#).  The ability to  reject H-2 ~ marrow cells is under genetic control of two or more dominant 
genes which segregate independently from H-2  (17).  Recipient mice were exposed to 800 rads of 
total-body  irradiation  in  a  small  animal  irradiator  with two  lsTCs sources  (Gamma  Cell  400, 
Atomic Energy of Canada,  Ltd.,  Toronto).  Each mouse was infused intravenously with 4  x  106 
bone marrow cells in a  vol of 0.5 ml within 2 h  of irradiation. Proliferation of the donor-derived 
cells in the spleens of recipient mice was assessed by measuring the incorporation of 5-iodo-2'- 
deoxyuridine-~2~I (IUdR), a  specific DNA precursor and thymidine analogue. The mice were each 
injected with 10 -7 M  5-fluoro-2'-deexyuridine (FUdR) i.p.  in a  vol of 0.1 ml  1 h  before the i.p. 
injection of 0.5/zCi IUdR. FUdR inhibits endogenous thymidylate synthesis and enhances IUdR 
uptake, under these conditions. Spleens were removed 2 h  after isotope injection, were soaked in 
70% ethanol for 3 days to remove 12sI not incorporated into DNA,  and the 125I radioactivity was 
measured in a  crystal scintillation counter (Packard Instrument Co., Inc., Downers Grove, Ill.). 
DBA/2  and  B10.D2  mice  have  been  reported  to  reject  1  x  10  e H-2  ~ bone  marrow  cells  (18). 
However, in preliminary experiments with 2  x  106 and 4  x  10  ~ B6 (H-2 b) bone marrow cells, we 
found that DBA/2 mice were unable to reject 4  x  10  e B6 bone marrow cells while B10.D2 mice 
could reject them.  With this inoculum size of bone marrow cells,  we could clearly classify the 
DBA/2  mice  as  "poor  responders" and  B10.D2  mice  as  "good  respenders" to  B6 bone marrow 
grafts. Therefore, 4  x  106 B6 marrow cells were used to type the (DBA/2 x  B10.D2)F2 mice. 
Experimental  Protocols.  To  type  individual  mice  both for Fv-2  and susceptibility of their 
lymphocytes to suppression by FV in vitro, two protocols were used (Fig. 1): (i) (B6 x  129)F2 mice 
were infected with 50 FFU of N-B tropic FV intravenously; 9 days later mice were killed and the 
spleen and thymus from each mouse was removed.  Spleens were fixed individually in Bouin's 
fluid to detect presence or absence of foci and thymus cells were cultured  (after three washes 
with medium) with and without Con A and/or FV, to detect degree ofimmunosuppression by FV. 
In preliminary experiments we observed that washed thymus  cells from mice infected 9  days 
earlier  with  FV  responded  normally  to  Con  A  and  that  there  was  no  difference  in  their 
FIG.  1.  Experimental protocols for testing individual mice for susceptibility to FV-induced 
spleen focus formation in vivo and suppression of lymphocyte mitogenesis in vitro. A. (129 
×  B6)F~  mice.  B.  (DBA/2  ×  B10.D2)F2,  (DBA/2  x  B10.D2)F~  x  DBA/2,  and  (DBA/2  x 
B10.D2)F1  x  B10.D2 mice. Some of these mice were typed for susceptibility to suppression 
of lymphocyte mitogenesis and ability to reject C57BL/6 bone marrow cells. KUMAR,  GOLDSCHMIDT,  EASTCOTT,  AND  BENNETT 
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TABLE  I 
Suppression of Con A Induced Mitogenesis  of Resistant and Susceptible  Parental 
Strains and their F1 Hybrids by FV In Vitro 
Lymphoid  h Blastogenesis*  Suppres- 
Exp.  Mouse strain  cell* source  sion 
No  FV  +FV§ 
cpm ± SE  % 
B10.D2n  Spleen  23,456 ±  1970  20,571 ± 2152  13 
DBA]2  Spleen  41,673 ±  1123  19,662 ± 2012  53 
(DBA/2 x  B10.D2)F1  Spleen  30,259 ± 750  17,015 ±  1411  44 
2.  C57BL/6  Thymus  17,566 ±  1719  18,460 ± 3125  -5 
129  Thymus  32,971 -+ 2005  10,523 ± 975  69 
(129 x C57BL/6)F1  Thymus  35,721 +- 4123  9,923 ± 575  73 
* 1 ×  10  e spleen cells per well and 6 ×  10  e thymus cells per tube were cultured as described  in 
Materials and Methods. 
,  A blastogenesis, (cpm with mitogen-cpm without mitogen). In groups with FV, h blastogenesis, 
(cpm + mitogen + FV -  cpm +  FV). 
§ The final concentration of FV in spleen cell cultures was 300 FFU/well and 300 FFU/ml in 
thymus cell cultures. 
susceptibility to FV in vitro as compared to thymus cells from  uninfected mice (Fig.  1 A).  (ii) 
Despite the fact that thymocytes from FV infected mice behaved normally in vitro (above), it was 
considered  desirable to use lymphocytes from uninfected mice and then infect the mice for Fv-2 
typing. Progeny of (B10.D2 x  DBA/2)F1 x  F1, DBA/2, and B10.D2 matings were anesthetized 
with chloral hydrate and a hemisplenectomy was performed.  A suture was tied in the middle of 
the spleen, with care taken not to occlude blood vessels in the hilus. There was minimal bleeding 
after the spleen proximal to the suture was severed.  There was a 5% operative mortality rate. 
The one-half spleen removed was used to make a cell suspension for culture with Con A and/or 
FV.  10 days after surgery, each mouse was infected with 50 FFU of FV. 9 days after infection, 
the residual spleen was removed and fixed in Bouin's fluid for focus counting. Although there 
were some adhesions on the surface of the spleen, the foci were easily detectable (Fig.  1 B). 
A protocol similar to (ii) was used to type mice for ability to reject marrow allografts (Fig. 
1 B). 10 days after hemisplenectemy and spleen cell culture, individual  mice were irradiated (800 
rads)  and infused with 4  x  10  e C57BL/6 bone marrow cells.  IUdR uptake (%) was measured 5 
days after cell transfer. There was a 15% incidence of mortality after irradiation. 
Results 
Dominance for Susceptibility to Immunosuppression by FV In Vitro.  Spleen 
cells or thymus cells from adult untreated mice were cultured in the presence 
or  absence of FV  and  Con  A.  The  donors  were  DBA/2,  B10.D2,  (DBA/2  x 
B10.D2)F1, 129, B6, and (129  ×  B6)F1 mice. Cells were pooled from two or three 
donors.  T  cells from mice genetically resistant to  FV-induced leukemia, i.e., 
B10.D2 and B6,  were relatively resistant to suppressive effects of FV  (Table I 
and reference  10),  whereas  cells from  susceptible  DBA/2  and  129  mice  were 
quite susceptible. Both (DBA/2  ×  B10.D2)F1 and (129  ×  B6)F1 spleen cells were 
also  susceptible  (Table I),  indicating that  the  gene(s) for  susceptibility were 
dominant  over the  gene(s)  for  resistance.  In these,  as  in other  experiments 
(10), the lack of importance of H-2 type was apparent, since DBA/2 and B10.D2 
mice are H-2  d and 129 and B6 mice are H-2  b. 
A  Single  Gene  Controls  Resistance  to  Immunosuppression  by  FV  In 
Vitro.  Parental-strain  129  and  B6  mice  and  30  (129  x  B6)F2  mice  were KUMAR,  GOLDSCHMIDT,  EASTCOTT,  AND  BENNETT  427 
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Fro.  2.  Typing of individual intercross  and backcross mice for susceptibility  to spleen 
focus  formation in vivo and suppression of  Con A induced lymphocyte mitogenesis by FV 
in vitro. Mice positive  for spleen loci (O); negative for foci (@). The mean percent 
suppression of  Con A response (-SE), for  the parental strains  was: 129 =  46.6 ±  28.4, B6 
=  -26.6 ±  7.6,  DBA/2  =  68.7 ±  21.7, B10.D2 =  2 _+ 13.9. Details  of  experimental protocol 
and criteria  for  phenotypic classification  in vitro  given in the text.  Result:  no correlation 
seen between susceptibility  to spleen focus  formation and susceptibility  to suppression of 
the Con A response. 
individually tested for resistance to FV in vitro, with the thymus cell cultures. 
In this experiment,  129 thymus cells were suppressed 10-70% while B6 thymus 
cells were actually "stimulated" by the addition of FV to the cultures  (Fig.  2). 
With these criteria  6/30 of the (129  ×  B6)F2 progeny had thymocytes resistant 
to FV while  24/30 had susceptible thymocytes  (Table  II and Fig.  2 A).  A  Chi- 
square analysis indicates that this finding is most consistent with the hypothe- 
sis that a single gene dominant for susceptibility controls the response to FV in 
vitro. A  two-gene hypothesis was also tested but did not fit the data well. 
A  similar analysis was performed utilizing spleen cells from parental-strain 
DBA/2 and B10.D2 mice, as well as (DBA/2  x  B10.D2)F2,  [(DBAJ2  ×  B10.D2)F1 
x  DBA/2]  BC1  and  [(DBA/2  ×  B10.D2)F1  x  B10.D2]  BC1  mice.  In  these 
experiments  the range of suppression of Con A  response of the DBA/2  parent 
with 300 FFU of FV in vitro varied from 40 to 80% while  that of the B10.D2 
parent varied from -20 to 20%. These criteria were therefore used to judge the 
phenotypes of individual intercross mice. Spleen cells of 54 (DBA/2  x  B10.D2)F~ 
mice  were  tested:  37/54  were  susceptible,  14154  were  resistant  and  3/54  had 
indeterminant  values  (20-40%  suppression  [Table  II]).  A  Chi-square  analysis 
again supported the one-gene hypothesis and not a two-gene hypothesis  (Table 
II).  Some of these mice were  also tested  for Fv-2  and the values are  given in 
Fig.  2 B. 
20  individual  [(DBA/2  ×  B10.D2)F1  ×  B10.D2]  BC1  mice  were  typed  for 
susceptibility to FV in vitro. With the above mentioned criteria for judging the 428  GENETICS  OF  FRIEND  VIRUS  IMMUNOSUPPRESSION 
TABLE II 
Observed and Expected Numbers of Mice Resistant or Susceptible to FV In Vitro, if a 
Single Dominant Gene were Responsible for Susceptibility 
Resistant  Susceptible 
Number  X2  p, 
Mating type  typed  Expected  Observed  Expected  Observed 
1.  (129  x  B6)F2  30  7.5  6  22.5  24  0.4361  >0.1 
2,  (DBA/2 ×  B10.D2)F2*  54  13.5  14  40.5  37  0.1633  >0.1 
3,  [(DBA/2 × B10.D2) x  BI0.D2]$  20  10  8  10  9  0.4285  >0.1 
4. [(DBA/2  x BIO.D2)  x DBA/2]  12  0  O  12  12  0 
* Data from all the crosses  were significantly different (P <  0.005) from the expected numbers if  two genes were controlling 
susceptibility.  [;~2 values =  9.680,  39.1229,  11.5714 for mating type 1, 2, and 3, respsctively.) 
Three mice in each group were indeterminate (see text for criteria of phenotypic classification). 
phenotype of the backcross mice,  it was found that  three mice fell within the 
range  of 20-40%  (22,  22,  and  34%)  suppression  of Con  A  response,  i.e.,  in 
between  the  ranges  of the  parental  types,  and  were  therefore  considered 
"indeterminate" for the purpose of Chi-square analysis.  Of the remaining  17, 8 
could  be  clearly  classified  as  resistant  to  suppression  in  vitro  (suppression 
<20%) and 9 were classified as susceptible (>40% suppression).  A  Chi-square 
analysis supports the one gene hypothesis suggested by analysis of the previous 
two crosses (Table II, Fig. 2 C). 
If a  single dominant  gene  were controlling  susceptibility to suppression  in 
vitro,  it would be expected that  100% of the  [(DBA/2  x  B10.D2)F1  x  DBA/2] 
BC1 mice would be susceptible to FV-induced suppression in vitro. Analysis of 
12 DBA/2 backcross mice showed that each mouse was susceptible to suppres- 
sion (>40%) in vitro (Fig. 2 D, Table II). 
Independent Segregation  of the Gene Controlling Susceptibility  to Immuno- 
suppression  by FV In Vitro and Fv-2.  The data in Fig. 2 graphically indicates 
that Fv-2  type does not correlate with the degree of suppression of mitogenic 
responses  of lymphocytes  by  FV.  Of 30  (129  x  B6)F2  mice  tested,  6  were 
resistant to focus-formation in vivo, i.e., were Fv-2 rr, whereas 24 were suscep- 
tible  (Fig.  2 A).  Among the six Fv-2  ~  F2 mice, five had thymocytes mildly to 
profoundly suppressed by FV and one had thymocytes resistant to FV in vitro. 
5 of 24 mice susceptible to focus-formation in vivo,  i.e., Fv-2  "s or Fv-2%  had 
thymocytes resistant to suppression by FV in vitro. The other 19 had thymocytes 
susceptible to FV in vitro (Fig. 2 A). A Chi-square analysis of the data supports 
the hypothesis that the genes are not linked (X  2 =  0.8146 P  >  0.1). 
In a similar analysis of 20 (DBA/2 x  B10.D2)F2 mice, there was no correlation 
between resistance to focus-formation in vivo and to suppression of mitogenesis 
in vitro  (Fig.  2 B). All Fv-2  ~  mice had spleen cells susceptible to FV in vitro 
and 2/15 mice susceptible to focus-formation in vivo had spleen cells resistant 
to FV in vitro. The fraction (2/20) of these mice with resistant spleen cells was 
low, but subsequent experiments with larger numbers of spleen cell suspension 
from individual F2 mice resulted in a larger fraction, i.e.,  14/54  (Table II). The 
data  support  the  hypothesis that Fv-2  and  the  gene  for resistance  to  FV  in 
vitro segregate independently  (×2 =  2.75 P  >  0.1). 
Of the  20  [(DBA/2  x  B10.D2)F1  x  B10.D2]  BC1 mice tested,  3 had  spleen 
cells of "indeterminant"  susceptibility to FV in vitro  (Fig.  2 C, Table II).  The 
data, as analyzed by a  Chi-square formula, indicate that Fv-2 and the gene for KUMAR,  GOLDSCHMIDT,  EASTCOTT,  AND  BENNETT  429 
susceptibility segregate independently  (X  ~ =  3.00 P  >  0.1).  There  were eight 
Fv-2 rr mice and spleen cells from three were susceptible to FV in vitro. 
All 12  [(DBA/2  x  B10.D2)F1  x  DBA/2] BC1 mice were susceptible to focus- 
formation in vivo and their  spleen cells were susceptible to FV in vitro  (Fig. 
2 D).  The data confirm the finding that susceptibility is dominant  over resist- 
ance to FV in vitro. 
Different Genes Control Ability to Reject Marrow Cell Allografts and Suscep- 
tibility  to FV In  Vitro.  Mice  of the  C57BL background,  including  B6,  B10, 
and B10 congenic strains,  are able to reject marrow cell allografts of several H- 
2  types  (19)  and  their  lymphocytes  are  resistant  to  FV  in  vitro  (10).  The 
immune  response  (Ir)-like  genes controlling  this  ability are multiple  (two or 
more)  and "good responder"  status  is dominant  over "poor responder"  status 
(19).  Despite these  differences,  we decided to  test the hypothesis  that  one of 
such  genes  is  linked  to  or identical  with  the  gene  determining  resistance  of 
lymphocytes to FV in  vitro.  Therefore,  individual  (DBA/2  x  B10.D2)F2 mice 
were hemisplenectomized  and  their  spleen  cells were tested for resistance  to 
FV in  vitro  (Fig.  1).  10  days later,  the  mice were irradiated  (800  rads)  and 
challenged  with  inocula  of 4  x  106  B6  (H-2 b)  bone marrow  cells.  Previously 
hemisplenectomized  DBA/2  '~poor  responder"  and  B10.D2  ~'good  responder" 
were irradiated and challenged with B6 marrow cells as controls for classifying 
the F2 progeny mice. The geometric mean (95% confidence limits) IUdR uptake 
(%) values in spleens of DBA/2 and B10.D2 recipients,  respectively, were 0.40 
(0.17-0.92) and 0.04 (0.02-0.06). 
The  data in  Fig.  3 depicts the relationship  between responder  status to B6 
marrow grafts and susceptibility of spleen cells to FV in vitro. 16 of the 20 mice 
were  "good  responders"  to  B6  marrow  cell  allografts  and  4/20  were  "poor 
responders",  as judged  by splenic  IUdR uptake  (%)  values  5  days  after  cell 
transfer.  The  degree of suppression  of response  of the  spleen  cells to  Con A 
ranged from 3 to 76% when taken from the 16 '~good responder"  mice (Fig.  3), 
indicating  a  lack  of correlation  between  ability  to  reject  allogeneic  marrow 
cells  and  resistance  to  FV  in  vitro.  The  percent  suppression  values  of the 
spleen cell cultures from "poor responder" mice were within the same range as 
spleen cell cultures of the "good responder" mice. 
Discussion 
Friend leukemia virus complex causes erythroleukemia and profound immu- 
nosuppression  in  susceptible  strains  of mice.  We  have  previously  described 
that mitogenic response of normal T and B cells from various lymphoid organs 
of mice  susceptible to  FV leukemia  is suppressed  by addition  of FV in vitro 
(10).  Suppression of the  mitogenic response is mediated by T-suppressor cells 
and  is  under  genetic control  (13).  Lymphoid cells from mice resistant  to  FV 
leukemia  are  refractory to suppressive effects of FV in vitro.  However, such 
resistance  is lost when M  cells are eliminated  by treatment  of mice with ~Sr 
(10). This and other evidence led us to postulate that M cells serve to regulate 
the  number  and/or  functions  of T-suppressor  cells.  In  mice  with  lymphocyte 
populations genetically resistant to FV in vitro, the number of suppressor cells 
is  maintained  at  a  low level,  thus  affording  them  protection  from  immuno- 430  GENETICS  OF  FRIEND  VIRUS  IMMUNOSUPPRESSION 
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FIG.  3.  Typing  of individual  (DBA/2  ×  B10,D2)F2  mice  for  ability  to  reject  C57BL/6 
marrow allografts and susceptibility to suppression of lymphocyte mitogenesis. Result: no 
correlation exists between susceptibility to suppression of lymphocyte mitogenesis by FV 
and marrow allograft reactivity. 
suppression in vitro (13).  These studies led to two important questions: (a) 
what is the nature and number of genes which regulate the suppressor cell 
number and/or functions and thus susceptibility  to suppression in vitro?  (b) Do 
the genes which regulate the T-suppressor cells  detected in vitro  also  function 
similarly  in vivo? We have attempted to answer the first  of  these two questions 
in the present paper. 
The first  known gene we considered that may regulate susceptibility  to FV 
in vitro  was Fv-2 (6).  Until the present genetic analysis was performed, all 
evidence indicated that inbred mice typed as Fv-2  rr also had lymphocytes 
resistant  to FV in vitro (10).  Susceptibility  to focus-formation and to immuno- 
suppression in vitro is dominant over resistance (6 and Table I). Finally, 
treatment of  genetically resistant adult C57BL/6 mice with S~Sr  to deplete M 
cells  abolished the resistance  to  the malignant erythropoietic  effects  (a  function 
of  Fv-2) and to the immunosuppressive effects  (both in vivo and in vitro)  of  FV 
(9, 10).  However, the analysis presented in Fig. 2 clearly  indicates that Fv-2 
and the gene controlling  susceptibility  to immunosuppression by FV in vitro 
segregate independently. In every cross,  some mice susceptible  to spleen focus 
formation had lymphocytes resistant to FV  in vitro and mice resistant to 
spleen focus formation had lymphocytes susceptible to FV in vitro.  This was 
true whether spleen or thymus cells  were tested. 
The observed and expected numbers of  mice susceptible  in vitro  to immuno- 
suppression ifa  single  gene dominant for  suppression were involved  is  presented 
in Table II. Notwithstanding the three indeterminants in the group of  (DBA/2 
×  B10.D2)FI  ×  B10.D2 backcross mice, the data best fits  the single gene 
probability.  Of  the total  number of  116 mice tested,  the number of  mice which 
could not be classified  clearly  as resistant  or susceptible,  i.e.,  "indeterminants" 
was 5 or 4%. We do not believe that this  small percent significantly  affects  our 
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The/r-like genes which control relative ability to reject marrow cell allografts 
(17) could possibly have regulated the resistance to FV immunosuppression in 
vitro.  The/r-like genes are multiple  (two or more) and resistance is dominant 
over susceptibility (17), in contrast to the gene regulating resistance to FV in 
vitro.  However, treatment  of adult  mice with  S~Sr abrogates both the/r-like 
gene functions (11) as well as resistance to immunosuppression by FV (9,  10), 
indicating that M cells are involved in both types of gene functions. The/r-like 
genes detected so far are not linked to H-2  (17) and mice of the C57BL genetic 
background are "good responders" to most types of immunogenic  marrow cell 
grafts  (19)  and  are  resistant  to  FV  in  vitro.  However,  the  data  in  Fig.  3 
indicates  that  the  ability  of H-2 d  (DBA/2  ×  B10.D2)F~  mice  to  reject H-2 b 
C57BL/6 marrow cell grafts did not correlate with the resistance of their spleen 
cells to FV in vitro.  However, this  statement  is subject to qualification  since 
the ability to reject marrow grafts is determinant specific (20) and therefore the 
/r-like genes studied by us were specific for the H-2 b test graft used by us. In 
view of this,  the only definitive statement that  can be made from our data is 
that/r-like  genes regulating  ability to reject H-2 b marrow  cell grafts  do not 
control the resistance to immunosuppression by FV in vitro. 
The  gene  is  not  X-linked  as  sex of the  individual  mice test  or  sex  of the 
parents  in the matings  had  no effect on resistance  or susceptibility to FV in 
vitro (data not shown). 
In  summary,  a  single  autosomal  gene  appears  to  regulate  the  in  vitro 
susceptibility of lymphocytes to the suppressive effects of FV.  This gene most 
likely functions on the M cell T-suppressor cell relationship  (13).  Because this 
gene also regulates the immunosuppressive effects of FV in vivo, 2 we propose 
that this gene be called Fv-3.  Inbred strains tested by us and classified as Fv- 
3 ~r include C57BL/6,  C57BL/10,  and B10 congenic mice,  C58 and HTG. Fv-3" 
strains  include  129,  DBA/2,  BALB/c,  CBA,  SIM,  SIM.R,  C3H,  SJL,  NZB, 
NZW, and A.  Non-inbred Swiss mice of various types are also Fv-3 "s. 
How might Fv-3 govern M cell T-suppressor cell interaction? The answers to 
this question are not provided by this study, but two possible mechanisms may 
be suggested.  First, Fv-3  could affect the antigenicity of suppressor cells such 
that  they are  recognized  and  eliminated  by M  cells.  Alternately,  Fv-3  may 
affect the ability of M cells to recognize and/or interact with T suppressor cells. 
The  former  of these  two  possibilities  would  imply  that  only  mice  with  the 
genotype Fv-3 ~  would express the antigens  on suppressor cells which can be 
recognized by M cells. This appears to be a  more appealing possibility since it 
is already known that homozygosity is a requirement for optimal expression of 
hemopoietic histocompatibility  (Hh)  antigens  associated with the H-2  region 
(21).  Hh antigens  are  normally  expressed on  marrow  stem cells  and  are the 
antigens known to be recognized by M cells (19). 
There  are  other  possible  gene  functions  of the  C57BL  background  that 
deserve  investigating  for  a  possible  relationship  to  Fv-3.  The  resistance  to 
infection with Listeria  monocytogenes,  a facultative intracellular bacterium, is 
under genetic control, and C57BL/6 mice are resistant (22). Moreover, treatment 
of adult  mice  with  S9Sr to  deplete  M  cells  weakens  the  resistance  to  this 
bacterium (23).  Herpes simplex-1 virus resistance is also under genetic control 432  GENETICS  OF  FRIEND  VIRUS  IMMUNOSUPPRESSION 
and C57BL/6 mice are resistant while A  strain mice are susceptible  (24). It is 
therefore conceivable that Fv.3  functions in resistance to nononcogenic infec- 
tions as well as in resistance to FV. 
Summary 
Friend leukemia virus (FV) suppresses  the proliferative response of normal 
lymphocytes to mitogens.  The in vitro suppressive effect of FV on lymphocyte 
mitogenesis is mediated by T-suppressor cells and is under host genetic control. 
Lymphocytes from strains of mice of the C57BL background (e.g., C57BL/6) are 
resistant while cells from other strains  (e.g.,  129 and DBA/2)  are susceptible. 
Genetic analyses utilizing resistant and susceptible parental strains,  their F1, 
intercross  and  backcross  progeny  indicated  that  susceptibility  to  in  vitro 
suppression is regulated by a single autosomal gene, dominant for susceptibility 
to suppression.  This gene, which is not linked to the H-2  complex, segregated 
independently  of  the  Fv-2  gene  which  controls  resistance  to  spleen  focus 
formation in vivo. The gene is also unlinked to the/r-like genes which regulate 
the  ability  of H-2 d  mice  to  reject  H-2 b  bone  marrow  grains.  The  gene  is 
therefore designated  as Fv-3.  Fv-3  may mediate  its  effect by regulating  the 
numbers and/or functions of T-suppressor cells. 
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